CD4 and metabolic dysfunction-associated steatotic liver disease: The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined in the advanced MASLD patients [3.57 (2.15-4.97) vs 6.56 (4.75-9.97), p=0.009] compared to the control subjects.